We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Revealing Early Stages of Alzheimer's Disease with MRI

By MedImaging International staff writers
Posted on 18 May 2010
A major Australian study has provided new clues into the loss of structure in areas of the brain and its potential association with Alzheimer's disease (AD). These findings suggest an accumulation of deposits of the protein amyloid-beta in a region of the brain known as the temporal inferior cortex. The region is connected to the hippocampus, which is involved in memory.

AD is characterized by two factors: a build-up of amyloid-beta plaques in the brain, and a loss of neurons. The Commonwealth Scientific and Industrial Research Organization's (CSIRO; Victoria, Australia) Preventative Health flagship theme ;leader, Dr. Cassandra Szoeke, reported the mystery for researchers was that the parts of the brain that had shrunk (atrophied) due to neuron loss were not the same as those showing increased deposits of amyloid-beta.

Using magnetic resonance imaging (MRI) scans to assess Alzheimer's disease-affected brain tissue, the researchers discovered that shrinking (atrophy) of the hippocampus was associated with plaque deposits in the temporal inferior cortex. The study's findings indicate that the increased accumulation of amyloid in the temporal inferior cortex disrupts connections with the hippocampus, causing the neurons to die. "By helping to better understand the mechanisms involved in the progression of the disease, the study may guide the development of new strategies for early diagnosis,” Dr Szoeke said.

The study involved advanced techniques for analyzing and comparing different types of brain scans. Lead researcher was Dr. Perrick Bourgeat, from the Australian e-Health Research Center (Queensland, Australia)--a joint venture between CSIRO and the Queensland Government.

The Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) Study is being undertaken by CSIRO, the University of Melbourne, Edith Cowan University (Perth), Neurosciences Australia (Victoria), and the Mental Health Institute of Victoria.

The study's findings were reported in April 2010 issue of the journal Neurology.

Related Links:
Commonwealth Scientific and Industrial Research Organization
Australian e-Health Research Center


Gold Member
Ultrasound System
FUTUS LE
Gold Member
Electrode Solution and Skin Prep
Signaspray
Ultrasonic Diagnostic System
K10
X-Ray Generator
RF Series

Latest MRI News

AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans
18 May 2010  |   MRI

AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
18 May 2010  |   MRI

Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
18 May 2010  |   MRI